Abstract: An adjustable mattress structure comprises a mattress body in which there are a plurality of hollow bases, a plurality of elastic support units, a plurality of adjustable positioning boards and a plurality of spring positioning bodies. Each of the elastic support units consists of a first encapsulated elastomer and a second encapsulated elastomer. The first encapsulated elastomer depends on spring positioning bodies to be fixed on one of the hollow bases so that the second encapsulated elastomer extends inside the hollow base. Each of the adjustable positioning boards is fixed inside a hollow base and used to receive a second encapsulated elastomer; the adjustable positioning boards in the hollow bases are situated at distinct positions by which the adjustable positioning boards make the elastic support units generate distinct resilient bearing capacities for adjustable mattress firmness supporting a body curve.

Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, lung, breast, mouse, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervix, ovary, and/or prostate cancer.

Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to globo H, SSEA3, and SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, skin, bone, lungs, breast, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervical, ovarian, and/or prostate cancer.

Abstract: An isolated antibody or an antigen-binding fragment thereof having a specific binding affinity to an epitope located within the domain 1 or domain 3 of human vascular endothelial growth factor receptor 2 (VEGFR2; SEQ ID NO: 74) is disclosed. The epitope within the domain 3 of the VEGFR2 is located between amino acid residues 250 and 270 of SEQ ID NO: 74. Use of the antibody or antigen-binding fragment thereof in the manufacture of a medicament for inhibiting tumor growth, tumor angiogenesis, and/or inducing cancer cell cytotoxicity in a subject in need thereof is also disclosed. Also disclosed is a method of detecting the presence of VEGFR2 in a tumor vascular endothelial cell or a cancer cell in a biological sample.

Abstract: A system for controlling a robot by brain electrical signal, includes a screen, an electronic signal detection device, and a host computer. The screen shows a plurality of icons thereon, and the plurality of icons flashes at different frequencies. The electrical signal detection device detects brain electrical signal when one of the plurality of icons is stared. The host computer stores a plurality of personal reference parameters corresponding to the plurality of icons of the screen. The host computer processes the brain electrical signal to get parameters of use, and compares the parameters of use with the plurality of personal reference parameters to choose and execute the icon which is stared.

Abstract: A cell for treating neurodegenerative disease treated with angelica extract is provided. The pharmaceutical composition comprises the cell for treating neurodegenerative disease and can significantly increase and recover the number of dopaminergic neurons to achieve the goal for treating neurodegenerative disease.

Abstract: Disclosed are a real number M-ary signal encoding method, where M is a real number having N time dimensions and L frequency dimensions, and an encoding apparatus using the encoding method. The real number M-ary encoding apparatus according to the present invention comprises a coding unit which codes every K (K is an integer) binary bit units of binary data DATA to generate a first input code and a second input code, a first signal generator which receives the first input code and generates N1 number of M1-ary signals, a second signal generator which receives the second input code and generates N2 number of M2-ary signals, and a first time division multiplexing module which temporally multiplexes the N1 number of M1-ary signals and the N2 number of M2-ary signals to generate a real number M-ary signal which utilizes a voltage ratio a (a=A2/A1) used for M1-ary and M2-ary signals to minimize a transmission error rate.

Abstract: A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof.

Abstract: A coaxial cable connector configured to be mounted to an externally threaded connector, comprising a nut portion having an inner thread configured to engage with an outer thread of said externally threaded connector, an inner-sleeve portion coaxially arranged with said nut and a first sleeve coaxially arranged with said nut, wherein said first sleeve comprises an inner flange radially on an outer wall of said inner-sleeve portion, characterized in that: when said nut is rotated relatively to said first sleeve, said inner-sleeve portion is rotated relatively to said first sleeve.

Abstract: A lighting apparatus includes a circuit board, a lighting element and a lens structure. The lighting element is disposed on the circuit board. The lighting element includes a lighting top surface and a lighting lateral surface adjoined to the lighting top surface and the circuit board. The lighting top surface has a center and an optical axis passing through the center. The lens structure covers the lighting element to receive a light from the lighting element. The lens structure includes an outer surface having a total reflection portion and a light outgoing portion surrounding the total reflection portion. The optical axis passes through the total reflection portion. The total reflection portion is configured to totally reflect a portion of light from the center. The light outgoing portion is configured to allow another light emitted from the center to leave away from the lens structure.

Abstract: A method for semiconductor devices on a substrate includes using gate structures which serve as active gate structures in a MOSFET region, as dummy gate structures in a JFET region of the device. The dummy gate electrodes are used as masks and determine the spacing between gate regions and source/drain regions, the width of the gate regions, and the spacing between adjacent gate regions according to some embodiments, thereby forming an accurately dimensioned transistor channel.

Abstract: Isolated mutant dengue virus E protein variants are disclosed. The variant comprises an amino acid sequence that is at least 80% identical to SEQ ID NO: 1 and has one or more amino acid residue substitutions at position corresponding to Asn8 (N8), Arg9 (R9), Val12 (V12) and/or Glu13 (E13). The variant may comprise an amino acid sequence that is at least 90% identical to the SEQ ID NO: 1 and lack an infection-enhancing antibody-binding motif comprising the amino acid sequence of SEQ ID NO: 28 at domain I. An isolated nucleic acid sequence encoding the variant, a plasmid expressing the variant, a plasmid expressing a virus-like particle comprising the variant, a DNA vaccine, and a method of detecting the presence of a dengue virus in a biological sample are also disclosed.

Abstract: An expansion card with homogenized light outputs and light-homogenizing device thereof are disclosed. The expansion card includes a circuit board and a light-homogenizing device. The circuit board includes a light-emitting device disposed on a first side edge. The light-homogenizing device includes a light-guiding body, a light-diffusion element, and a light-turning element. The light-guiding body includes a light-input side and a light-output side opposite to each other, and the light-input side is adjacent to the first side edge. The light-diffusion element is disposed on the light-input side of the light-guiding body and opposite to the light-emitting device. The light-diffusion element and the light-out side are configured to diffuse the light beams entering into the light-guiding body from the light-emitting device and form a light-transmitting path.

Abstract: A use of an emblica extract in preparing a pharmaceutical composition for protecting mitochondria in retina is provided. When the pharmaceutical composition, which comprises the emblica extract, is provided to retinal cells, a use of the pharmaceutical composition comprises improvement of the ability of performing the oxidative phosphorylation for the synthesis of the adenosine triphosphate (ATP) by the mitochondria in the retinal cells under or exposed to ultraviolet light, and improvement of the coupling efficiency of the synthesis of the adenosine triphosphate by the mitochondria.

Abstract: An apparatus for fastening a pair of gas vessels includes: a plurality of first units formed of a composite material, spaced apart from each other in parallel with each other in a length direction of the gas vessel, and having the pair of gas vessels seated on both sides thereof; a second unit formed of a composite material and extending in the length direction of the gas vessels to integrally connect the plurality of first units; and a plurality of fastening units each of which extending along a circumference of the gas vessels to enclose the gas vessels seated on the first units and having both ends connected to the first units.

Abstract: A high-pressure composite container having a gastight nozzle structure includes a metal nozzle formed at a side of an inlet of a plastic liner layer that defines an inner layer of the high-pressure composite container; a nozzle insert which is inserted into and attached to the metal nozzle in a direction from an inner side of the plastic liner layer to an outer side of the plastic liner layer; and a nut member fixed to an upper end portion of the nozzle insert.

Abstract: A coaxial cable connector configured to be mounted to an externally threaded connector, comprising a nut portion having an inner thread configured to engage with an outer thread of said externally threaded connector, an inner-sleeve portion coaxially arranged with said nut and a first sleeve coaxially arranged with said nut, wherein said first sleeve comprises an inner flange radially on an outer wall of said inner-sleeve portion, characterized in that: when said nut is rotated relatively to said first sleeve, said inner-sleeve portion is rotated relatively to said first sleeve.

Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.

Abstract: A liquid crystal polymer (LCP) composite film is provided. The LCP composite film includes 88 to 99 weight percent of a liquid crystal polymer based on the total weight of the LCP composite film and 1 to 12 weight percent of a toughening agent based on the total weight of the LCP composite film. The toughening agent includes a copolymer selected from a group consisting of a thermoplastic polyolefin elastomer, a glycidyl methacrylate copolymer, a polystyrene elastomer, a polyester elastomer, and a mixture thereof.

Abstract: A method for semiconductor devices on a substrate includes using gate structures which serve as active gate structures in a MOSFET region, as dummy gate structures in a JFET region of the device. The dummy gate electrodes are used as masks and determine the spacing between gate regions and source/drain regions, the width of the gate regions, and the spacing between adjacent gate regions according to some embodiments, thereby forming an accurately dimensioned transistor channel.